Cary, NC, United States of America

Ramesh Krishnamoorthy

USPTO Granted Patents = 7 

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Durham, NC (US) (2011)
  • Cary, NC (US) (2008 - 2023)

Company Filing History:


Years Active: 2008-2023

Loading Chart...
7 patents (USPTO):

Title: Ramesh Krishnamoorthy: Innovator in Ophthalmic Compositions

Introduction

Ramesh Krishnamoorthy is a notable inventor based in Cary, NC (US), recognized for his contributions to the field of ophthalmic compositions. With a total of seven patents to his name, he has made significant advancements in the development of pharmaceutical formulations aimed at improving eye health.

Latest Patents

Among his latest patents, Ramesh has developed innovative ophthalmic compositions that include 4-(3-amino-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl)benzyl 2,4-dimethylbenzoate or its pharmaceutically acceptable salts. These compositions also incorporate a buffer in concentrations ranging from about 0.01% weight/volume to about 1.0% weight/volume, along with a tonicity agent present in amounts from about 0.01% weight/volume to about 10% weight/volume. This formulation aims to enhance the effectiveness and comfort of ophthalmic treatments.

Career Highlights

Ramesh has worked with prominent companies in the pharmaceutical industry, including Inspire Pharmaceuticals, Inc. and Aerie Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions for eye care.

Collaborations

Throughout his career, Ramesh has collaborated with talented professionals such as Cheng-Wen Lin and Casey Kopczynski. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Ramesh Krishnamoorthy stands out as a significant figure in the field of ophthalmic compositions, with a strong portfolio of patents and a history of collaboration with esteemed colleagues. His work continues to impact the pharmaceutical industry positively, particularly in the realm of eye health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…